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Toll-like receptors (TLR) triggering of B cells are known to promote B cell expansion, dif-
ferentiation of B cells into antibody-producing and memory cells, but the TLR responses 
of porcine B cells is poorly characterized. Therefore, this study investigated the response 
pattern of porcine B cell subsets to a large collection of TLR ligands and demonstrates 
that the TLR2 ligand Pam3Cys-SK4 and the TLR7/8 ligands gardiquimod and resiquimod 
are particularly efficient at inducing proliferation, CD25 and CCR7. This activation was 
also determined in B-cell subpopulations including a CD21+IgM+ subset, an IgG+ subset 
and two putative B1-like subsets, defined as CD21−IgMhighCD11R1+CD11c+CD14+ and 
CD21−IgMhigh CD11R1−CD11c+CD14− B cells. The latter two were larger and expressed 
higher levels of CD80/86 and spontaneous phospholipase C-γ2 phosphorylation. All 
porcine B-cell subsets were activated by TLR2, TLR7, and TLR9 ligands. Naïve and 
memory conventional B cells responded similar to TLR ligands. The CD11R1+ B1-like 
subset had the highest proliferative responses. While both B1-like subsets did not spon-
taneously secrete IgM, they were the only subsets to produce high level of TLR-induced 
IgM. Similar to polyclonal IgM responses, memory B cells were efficiently induced to 
produce specific antibodies by CpG oligodinucleotide, resiquimod, and to a weaker 
extend by Pam3Cys-SK4. Depletion of plasmacytoid dendritic cells (pDCs) enhanced 
TLR-induced antibodies. The same set of TLR ligands also induced CD40 on cDCs, 
pDCs, and monocytes with the exception of TLR4 ligand being unable to activate pDCs. 
Gardiquimod and resiquimod were particularly efficient at inducing CCR7 on pDCs. 
Porcine B  cells expressed high levels of TLR7, but relatively little other TLR mRNA. 
Nevertheless, TLR2 on B cells was rapidly upregulated following stimulation, explaining 
the strong responses following stimulation. Subset-specific analysis of TLR expression 
demonstrated a comparable expression of TLR2, TLR7, and TLR9 in all B cell subsets, 
but TLR3 was restricted to B1-like cells, whereas TLR4 was only expressed on conven-
tional B cells, although both at low levels. Altogether, our data describe porcine innate 
B1-like cells, and how different B cell subsets are involved in innate sensing.
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inTrODUcTiOn
B cells are an essential component of the adaptive immune system and provide antibody-mediated 
protection against infections. After stimulation of surface immunoglobulin receptors and, in some 
cases, co-stimulatory T helper cell-derived signals, they respond with proliferation and affinity 
maturation of the antigen receptor, and finally differentiate into circulating memory B  cells or 
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antibody-producing plasma cells. In addition to these conven-
tional B cells also termed B-2 cells, B-1 cells with innate functions 
have been described in mice and men. These cells represent the 
main producers of natural immunoglobulin with polyspecific 
reactivity against self and microbial antigens (1).
Toll-like receptors (TLR) recognize conserved pathogen-
derived molecules and are central to the activation of innate 
immune defenses. TLR2 recognizes bacterial lipoproteins in 
heterodimer formation with TLR1 and TLR6 (2). TLR3 recog-
nizes double-stranded RNA (3), while TLR4 binds to bacterial 
lipopolysaccharide (LPS) (4), and TLR5 to bacterial flagellin (5). 
TLR7/8 single-stranded viral RNA (6) and TLR9 unmethylated 
microbial DNA containing CpG motifs (7–9). TLR ligands 
are typically described as targeting phagocytes and antigen-
presenting cells, which are efficient at activating innate immune 
responses that in turn promote adaptive immunity. In humans, 
B  cells express TLRs 1, 6, 7, 9, and 10. Their expression and 
response to stimulation through a particular TLR are enhanced 
in memory B cells (10, 11). Murine B cells express TLR1/2, TLR4, 
TLR7, and TLR9 (12–14).
Although T-cell mediated B cell activation can occur in the 
absence of TLR signaling (15), the B cell response to antigenic 
stimulation is enhanced when TLRs on B  cells are triggered 
(16, 17). In mouse models, intrinsic TLR signaling in B cells is 
important for IgG class-switching (18–21). This finding is of 
particular importance for T-independent antibody responses. 
Interestingly, in one study, only TLR9 ligands located within 
a virus-like particle triggered B  cell-intrinsic TLR-enhanced 
antibody responses, suggesting an important role for B cell TLRs 
during antiviral responses (20). This finding agrees with the 
observation that B cell intrinsic TLR stimulation is also important 
for controlling persistent virus infections (22–24).
Pigs are not only an important production animal but also 
represent an important large animal model than can complement 
traditional animal models such as the mouse. Considering the 
important role of TLR-induced signaling in B  cell responses, 
species-dependent differences in the response pattern, and the 
lack of information about this process in pigs, we investigated 
the response pattern of porcine peripheral B  cells to a large 
collection of TLR ligands. We found that TLR2 and TLR7/8 
ligands are particularly efficient at inducing B cell activation and 
proliferation, whereas TLR2, TLR7/8, and TLR9 stimulation 
promote antibody responses. We also analyzed the same set of 
TLR ligands for their ability to activate other antigen-presenting 
cells, altogether providing an in vitro evaluation of their potential 
as vaccine adjuvants.
MaTerials anD MeThODs
reagents
The TLR2 ligands Pam2Cys-Sk4, Pam3Cys-SK4, and CL429 
were acquired from EMC Microcollections, Germany. The 
TLR3 ligand polyinosinic-polycytidylic acid (poly I:C) was 
purchased from Sigma-Aldrich, Switzerland. The TLR4 
ligands Kdo2-Lipid A, monophosphoryl lipid A (MPLA), and 
lipid A detoxified were purchased from Avanti Polar Lipids, 
USA. The TLR4 ligand LPS (E. coli-derived) was acquired 
from Sigma-Aldrich. The TLR5 ligand Flagellin (FLA-ST, S. 
typhimurium-derived) was purchased from Invivogen, France. 
The TLR7 ligands loxoribine and gardiquimod, as well as the 
TLR7/8 ligand resiquimod were acquired from Chemdea 
(Ridgewood, NJ, USA), and the TLR7 ligand imiquimod 
was purchased from Invivogen. The TLR9 ligands CpG oli-
godinucleotide (ODN) D32 (5′-ggT GCG TCG ACG CAG 
ggg gg-3′), CpG 2007 (5′- tcg tcg ttg tcg ttt tgt cgt t -3′), and 
CpG 2142 (5′-TCGCGTGCGTTTTGTCGTTTTGACGTT-3′) 
were ordered from Eurofins, Switzerland. ODN D-SL01 
(5′-tcgcgacgttcgcccgacgttcggta-3′) and ODN D-SL03 (5′-tcgc-
gaacgttcgccgcgttcgaacgcgg-3′) were purchased from Invivogen 
or Eurofins, Switzerland. The positive control for proliferation 
concanavalin A (ConA) was acquired from Sigma-Aldrich.
CellTrace Violet stain was purchased from Thermofisher 
Scientific.
Monoclonal antibodies used included CD4 (clone 74-12-4; 
ATCC), CD14 (clone MIL2; Biorad, USA), CD16 (clone G7, 
Biorad), CD21 (clone BB6-11C9.6; Southern Biotech, USA), 
CD40 (clone G28.5, ATCC, USA), CD79a-APC (clone HM57, 
BioLegend, USA), CD80/86 (detection through human cytotoxic 
T-lymphocyte associated antigen-mouse immunoglobulin fusion 
protein; Enzo Biochem, USA), CD115 (clone ROS8G11-1; kindly 
provided by Prof. David Hume, Roslin Institute, University of 
Edinburgh, UK), CD172a (clone 74-22-15A, hybridoma kindly 
provided by Prof. Armin Saalmüller, Veterinary University, Vienna, 
Austria), CD172a-PE (Southern Biotech, USA), anti-IgM (clone 
PIG45A, ATCC), anti-IgG (23.7.1b, Thermofisher Scientific, 
Switzerland), anti-CD25 (clone K231.3B3, Biorad), and CADM1 
(clone 3E1, MBL International, USA). Anti-TLR2 antibodies 
were kindly provided by Dr. Javier Dominguez (Departemento de 
Biotecnología, Instituto Nacional de Investigación y Tecnología 
Agraria y Alimentaria, INIA, Madrid, Spain). Recombinant por-
cine IL-3 his-tagged (IL-3-his) was produced as described (25). 
Anti-his-tag antibody was purchased from Roche, Switzerland. 
Phosphorylated phospholipase (PLC)-γ2 was detected using 
Alexa Fluor® 647 mouse anti-PLC-γ2 (pY759) (clone K86-
689.37, Becton Dickinson). Anti-mouse secondary antibodies 
were purchased from Invitrogen (AF488, AF647, and PE-Cy5.5), 
Southern Biotech (FITC and PE), Abcam (PE-Cy7), and BD 
(V500 and V421 conjugates).
cells
Citrated blood was taken from a total of eight different pigs 
housed in our specific pathogen-free facility. Blood withdrawal 
was performed under the guidance of the Swiss animal welfare 
law, approved by the Cantonal ethical committee for animal 
experiments (BE88/14 and BE90/14). Peripheral blood mono-
nuclear cells (PBMCs) were prepared using density gradient 
centrifugation (1,000 × g, 25 min) over Ficoll-Paque (1.077 g/L, 
GE Healthcare Life Science). CD21+ B cells were isolated using 
magnetic cells sorting (MACS), following the manufacturer’s 
instructions (Miltenyi Biotec, Germany). PBMCs were cultured in 
DMEM + GlutaMAX (Thermofisher, Switzerland) supplemented 
with 10% fetal bovine serum (Thermofisher) and 0.02  mM 
beta-mercaptoethanol (Sigma-Aldrich) at 39°C and 5% CO2. 
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CD21-sorted B  cells were cultured in medium and conditions 
as described above, supplemented with HEPES, non-essential 
amino acids, sodium pyruvate (Thermofisher), and 50  U/ml 
recombinant porcine interleukin-2 (IL-2, kindly provided by Dr. 
S. Inumaru, National Institute of Animal Health, Ibaraki, Japan).
Peripheral blood mononuclear cells lacking plasmacytoid 
dendritic cells (pDCs) were obtained by depleting IL-3 receptor 
expressing cells as described (26). Briefly, PBMCs were incubated 
with porcine IL-3-his followed by anti-His-IgG (Roche), anti-
IgG-microbeads (Miltenyi Biotec). All incubations lasted for 
15 min on ice. After washing, cells were passed through an LD 
column and the negative fraction was collected on ice.
Purified B-cell subsets were obtained using FACS sorting. 
After PBMC preparation, T cells were depleted using the MACS 
system (Miltenyi Biotec). After incubation with anti-CD3 (clone 
PTT3/FyH2), cells were incubated with anti-mouse IgG mag-
netic beads (Miltenyi Biotec) and sorted using an LD column. 
The CD3− fraction was then stained with anti-CD21, IgM, IgG, 
and CD11R1 as described in the Section “Results”. After doublet 
exclusion and lymphocyte gating, CD21+IgM+ (P1), IgG+ (P2), 
CD21−IgM+CD11R1+ (P3), and CD21−IgM+CD11R1− (P4) cell 
subsets were defined by electronic gating and the four subsets 
sorted using a fluorescence activated cell sorting (FACS) Aria (BD 
Biosciences).
Detection of B-cell activation Markers
Peripheral blood mononuclear cells were seeded at 1  ×  106 
cells/500 μl and stimulated with TLR ligands for 17  h. Then, 
cells were harvested and stained for B cell subsets using anti-
IgM, -IgG, CD21, and CD11R1, combined with CD25 or CCR7 
as activation markers.
To quantify tonic B cell signaling, freshly isolated PBMC were 
first stained for surface markers, incubated for 2 min, then fixed 
and permeabilized (BD PhosphoflowTM reagents) and stained for 
PLC-γ2 (pY759).
Proliferation assays
Peripheral blood mononuclear cells were cultured in medium 
as described above at a concentration of 2  ×  106 PBMCs/ml 
in round-bottom microtiter plates They were stimulated with 
TLR ligands at the following concentrations: 10 µg/ml for TLR2 
ligands, 1 µg/ml for TLR4 ligands, 1 µg/ml for TLR5 ligands, 5 µg/
ml for TLR7/8 ligands, and 5 µg/ml for TLR9 ligands. The cells 
were incubated for 2 days, and 1 μCi 3H-thymidine per well was 
added during the final 18–24 h. Cells were harvested on glass fiber 
filters and radioactivity was quantified in a Microbeta 1640 Trilux 
counter (Perkin Elmer).
To identify proliferating cell populations, we used CellTrace 
Violet stain and multicolor flow cytometry. Fifty million PBMCs 
or enriched B  cells were resuspended in 1  ml PBS. CellTrace 
Violet was added followed by incubation at 37°C for 10  min. 
Next, 2 ml FBS was added to the suspension and it incubated at 
room temperature in the dark for 15 min. Cells were washed twice 
with PBS/EDTA and centrifuged at 350 × g at room temperature 
for 10 min. Cells were then seeded into round-bottom 96-well 
plates at 200,000 cells/well in 200  µl final volume, with TLR 
ligands at the concentrations described above. After incubation 
at 39°C/5% CO2 for 5 days, cells were stained with primary and 
secondary antibodies for B  cell subsets corresponding to the 
desired read-out. IgG block (Jackson Immunoresearch, USA) 
was performed before adding primary antibodies when using 
enriched B cells.
In Vitro Total igM Production
Peripheral blood mononuclear cells or purified B  cell subsets 
were cultured for 5–7 days culture at 39°C/5% CO2 at the con-
ditions indicated in the figure legends, and supernatants were 
harvested and frozen until analysis. In some cultures, 50 U/ml 
recombinant porcine IL-2 (kindly provided by Dr. S. Inumaru, 
National Institute of Animal Health, Ibaraki, Japan) and 10 ng/
ml recombinant porcine B-cell activating factor [BAFF, prepared 
as previously described (27)] were added. Nunc-Immuno 96-well 
plates (Sigma-Aldrich) were coated with anti-IgM antibody 
in PBS (clone 5C9, 1:200). After overnight incubation at room 
temperature, plates were washed three times with wash buffer 
(PBS + 0.05% Tween 20) and blocked with PBS/0.5% BSA/0.05% 
Tween 20 buffer at 37°C for 1  h. After washing, samples were 
transferred and plates incubated at 37°C for 2  h. Next, plates 
were washed three times and we added goat anti-pig detection 
antibody coupled with horseradish peroxidase (Bethyl, A100-
117P, 1:20,000) for 20 min at 37°C. After washing, the substrate 
OPD (Sigma-Aldrich) was added and absorbance was measured 
at 450 nm using VersaMax reader (Molecular Devices, USA).
Memory B cell restimulation
Two pigs were vaccinated with a commercial vaccine against 
FMDV A Iran 96 (kindly provided by Merial, Pirbright, UK) 
using a prime boost vaccination protocol with 4 weeks between 
injections. PBMCs from these animals were used 3–7  months 
after booster vaccination. Cells were cultured in 24-well plates at 
a concentration of 2 × 106 cells/well and stimulated with purified 
FMDV antigen (10 µg/ml 146S antigen derived from A Iran 96, 
kindly provided by Merial) and/or TLR ligands, and incubated 
for 7 days at 39°C, 5% CO2.
FMDV-specific antibodies were detected by ELISA. Plates 
were coated with 100 µl 1 µg/ml FMDV A Iran 146 S antigen 
in PBS and incubated over night at 4°C. After washing with 
PBS, the plates were blocked with 1% BSA in PBS for 1  h at 
room temperature. Then, samples were applied and incubated 
for 30 min at room temperature. After washing the plates with 
PBS, peroxidase-conjugated goat anti-swine IgG (Jackson 
ImmunoResearch, PA, USA) followed by the addition of TMB 
as substrate.
reverse Transcription-Polymerase chain 
reaction (rT-Pcr) for Tlr expression
B cells and monocytes were enriched with MACS using CD21 
and CD14 antibodies, respectively. Purified pDCs were obtained 
using fluorescence activated cell sorting (FACSAria, Becton 
Dickinson) based on their CD172a+CD4high phenotype (28). 
The purity of sorted cells was over 98%. The purified B  cell 
subsets P1–P4 were also obtained by FACS sorting as described 
above. After sorting, cells were washed and resuspended in 
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TriZOL for RNA extraction using an RNeasy mini kit (Qiagen, 
Switzerland). RNA was treated with RNase-free DNase I 
(Ambion, UK). RT-PCR was performed on a Thermocycler 
ABI 7500 (ThermoFischer). RNA expression levels were calcu-
lated based on 18S RNA levels. TLR2 forward primer, 5′-TAT 
CCAGCACGAGAATACACAGTTTAA-3′; TLR2 reverse primer, 
5′-CGAGTTGAGATTGTTATTGCTAATATCTAAAA-3′; 
TLR2 probe, 5′-CATTGGCTTCCCCAGACCCTGGA-3′; TLR3 
forward primer, 5′-AAAATCTCCAAGAGCTTCTATTAGCA 
A-3′; TLR3 reverse primer, 5′-TTGTATTTGATTTGATGACA 
ACTCTAATCTTT-3′; TLR3 probe, 5′-CGTGAAGAACTTGAT 
TTCCTTGGCAATTCTTC-3′; TLR4 forward primer, 5′-TGG 
CAGTTTCTGAGGAGTCATG-3′; TLR4 reverse primer, 5′-CC 
GCAGCAGGGACTTCTC-3′; TLR4 probe, 5′-CGGCATCATC 
TTCATCGTCCTGCAG-3′; TLR7 forward primer, 5′-CAGA 
AGTCCAAGTTTTTCCAGCTT-3′; TLR7 reverse primer, 5′-GG 
TGAGCCTGTGGATTTGTTG-3′; TLR7 probe, 5′-CAACTGGT 
ACATCAGCACCTCTCAAGCAGA-3′; TLR8 forward primer, 
5′-GATACCATTGCGGCGATAATATG-3′; TLR8 reverse 
primer, 5′-TTTACCTTGGCTAAGCACACATG-3′; TLR8 probe, 
5′-ATGTTGGCTGCCCTGGCTCACC-3′; TLR9 forward 
primer, 5′-GAGACCCTGCTGTTGTCCTACAA-3′; TLR9 
reverse primer, 3′-AGTTCCCCCCCACATCAA-5′; TLR9 probe, 
5′-CGCCTGAGGACCTGGCCAATGTG-3′.
Dendritic cell subset activation
Peripheral blood mononuclear cells were cultured in 12-well plates 
at 2 × 106 cells/ml in 2 ml. Cells were stimulated with TLR ligands 
and incubated for 5 h at 39°C/5% CO2. Next, cells were harvested 
and stained with markers for CD4, CD14, CD80/86, CD172a, 
CCR7, and CADM-1. Samples were read using a FACSCanto II 
and data were analyzed with FlowJo software. Monocytes were 
identified and gated as CD14 cells, conventional DC1 (cDC1) as 
CD14−CD4−CADM1+CD172low/− cells, cDC2 as CD14−CD4−CA
DM1+CD172+ cells, and pDC as CD14−CD4+CADM1−CD172low/+ 
cells (26, 29).
statistical analysis
Analysis was performed in Prism 7 (GraphPad, USA). All statisti-
cal analyses used parametric tests for paired samples. ANOVA 
with Greenhouse-Geisser correction followed by Tukey’s test was 
performed for multiple comparisons of the mean of each group 
with the control, and Dunnett’s test was used generate P values for 
each comparison. Where applicable two-way ANOVAs were per-
formed followed by Sidak’s multiple comparison tests. P-values 
were defined as follows: ****P < 0.0001; ***P < 0.001; **P < 0.01; 
*P < 0.05; ns: not significant. Correlation was calculated using the 
linear regression method.
resUlTs
strong B cell Proliferative response after 
PBMc stimulation with Tlr2, 7/8, and 9 
ligands
Stimulating TLRs in immune cells engages various pathways, 
resulting in surface marker upregulation, cytokine production, 
and cell proliferation. As a first step, we tested the stimulatory 
potential of TLR ligands by assessing their ability to induce pro-
liferation of whole PBMCs. We screened a set of 18 TLR ligands 
using a 3H-thymidine incorporation assay. We tested ligands 
described as stimulating TLR2/1 and TLR2/6 heterodimers, 
TLR3, TLR4, TLR5, TLR7, TLR8, and TLR9 (Figure 1A).
Pam3Cys-SK4, a TLR2/1 ligand, and Pam2Cys-SK4, a 
TLR2/6 ligand, induced proliferation 8–18-fold over control 
values. CL429 (a conjugate of a TLR2/1 ligand with a NOD 
ligand) induced lower levels of activation (2–7-fold over con-
trols). No significant difference between Pam3Cys-SK4 and 
Pam2Cys-SK4 was detected (Figure 1B). The TLR3 ligand Poly 
I:C, all TLR4 ligands and the TLR5 ligands flagellin induced no 
significant proliferation compared to controls. Among the TLR7 
ligands, imiquimod and gardiquimod induced potent prolifera-
tive responses in the range of those induced by Pam3Cys-SK4, 
while loxoribine was not active. Resiquimod, a TLR7/8 ligand, 
induced the highest proliferation of all ligands tested, with 
values 11–27-fold those of controls. For stimulation of TLR9, 
various CpGs were tested. The type A CpG D32 and the type 
B CpG2007 did not induce significant responses. CpG2142 
induced a proliferation up to 5-fold over controls. Type B ODNs 
D-SL01 and type C D-SL03 induced the highest proliferation 
of this group, with proliferation values 7 and 12 times those of 
controls, respectively.
We identified B cells as the main proliferating population after 
TLR ligand stimulation. To this end, we employed multicolor 
staining for B  cells (IgM+) and T  cells (CD3+), with CellTrace 
Violet stain as a proliferation marker. Interestingly, up to 80% 
of IgM+ cells proliferated when stimulated with the TLR7/8 
ligand resiquimod (Figure  1C), whereas no response or even 
suppression was found in T cells with the selected TLR ligands 
(Figure 1D).
Porcine B cell subsets Definition
To identify different cell subsets in peripheral blood, we estab-
lished multicolor staining for surface IgM, IgG, CD21, and 
CD11R1 expression. The CD11R1 molecule in pigs is recognized 
by cross-reactive CD11b antibodies but differ in its cellular dis-
tribution (30). After excluding doublets, we identified four B cell 
populations (Figure 2A). P1 was defined as IgM+CD21+ cells and 
is composed of mainly naïve B  cells (31). P2 represented IgG-
switched memory B cells. The two novel B-cell subsets P3 and P4 
were defined as CD21−IgM+CD11R1+ and CD21−IgM+CD11R1−, 
respectively.
To further characterize P3 and P4, we analyzed various param-
eters by flow cytometry (Figure  2B). Forward-scatter analysis 
showed that the two IgM+CD21− subsets were bigger compared 
P1 and P2. Both P3 and P4 also expressed higher levels of IgM 
when compared to P1. CD11c was shown to be expressed at high 
level on P3 and on a major part of P4 but not on P2. P3 and 
P4 were also found to express higher levels of CD80/86, when 
compared to P1 and P2. Only P3 expressed CD14.
The higher size and surface IgM levels is a characteristic of B-1 
cells (1) indicating that both P3 and P4 could represent the por-
cine equivalent of B-1 cells. Furthermore, as shown in Figure 2B, 
the phenotype of P3 was reminiscent to that of a subset of human 
FigUre 1 | Proliferative response of B cells in whole peripheral blood mononuclear cells (PBMCs) after stimulation with toll-like receptor ligands. (a) Proliferation of 
PBMCs after stimulation for 3 days was determined using a 3H-thymidine assay. The fold increase over the medium control is shown. (B) Heatmap giving an 
overview of the statistical significances found between the treatments shown in (a). (c) Proliferation of IgM+ B cells determined by flow cytometry using 
CellTraceViolet. The percentage of proliferating cells in the IgM gate is shown. (D) Proliferating CD3+ T cells, again determined using CellTrace Violet. The percentage 
of proliferating cells in the CD3 gate is shown. (a,c,D) PBMC culture triplicates from three different animals, each depicted by a different shape. Mean values are 
indicated by horizontal bars. Error bars show SDs. Statistical significance was calculated using ANOVA followed by Tukey’s test (****P < 0.0001; ***P < 0.001; 
**P < 0.01; *P < 0.05; n.s., not significant).
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B-1 cells expressing high levels of CD11b, CD11c, CD14, and 
CD86 (32, 33). We therefore also tested if P3 and P4 had a higher 
level of tonic intracellular signaling, a characteristic of B-1 cells 
(32, 34) by analyzing their expression of phosphorylated PLC-
γ2, and found this to be elevated when compared to P1 and P2 
subsets (Figure 2B).
Contrasting with monocytes and blood DC (29), none of 
the B-cell subsets expressed CD115 and CD172a. We therefore 
propose that P3 and P4 represent innate B cell subsets with B-1 
like functions.
activation Marker response of B cells to 
Tlr stimulation
To evaluate the responses of the B-cell subsets P1–P4 to TLR 
stimulation, PBMCs were stimulated with the most potent TLR 
ligands identified in the screening experiments shown in Figure 1. 
Pam3Cys-SK4 and resiquimod induced strong upregulation of 
CD25 in all subsets (Figures  3A,B), while responses to ODN 
D-SL03 induced upregulation in all subsets with the exception 
of P3. This population was also less responsive to Pam3Cys-SK4 
when compared to resiquimod. We also compared the relative 
responsiveness of the B-cell subsets by calculating the fold-
increase in CD25 expression induced by TLR stimulation. While 
the response of P1 and P2 were comparable (6–7-fold increase 
of CD25 following resiquimod stimulation), P3 was found to be 
particularly responsive to resiquimod (17-fold increase). P4 was 
the subset with the overall lowest TLR responsiveness (3.3-fold 
increase).
Also, when analyzing CCR7 we found the strongest induction 
by Pam3Cys-SK4 and resiquimod (Figure 3C). In this assay, P1 
and P2 were unresponsive to ODN D-SL03. Furthermore, no 
upregulation of CCR7 was detected in P4 after stimulation.
FigUre 2 | B cell subsets in peripheral blood of pigs. (a) Gating strategies for identifying B cell subsets based on expression of IgG, IgM, CD21, and CD11R1. 
After doublet exclusion, population 1 (P1) was defined as CD21+IgM+, P2 as IgG+, P3 as CD21−IgM+CD11R1+, and P4 as CD21−IgM+CD11R1−. (B) Histogram 
overlays of FSC, IgM, CD11c, CD80/86, CD14, phosphor-PLC-γ2, CD115, and CD172a for the subsets P1–P4 identified in (a). A representative animal out of three 
is shown.
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cD11r1+ B-1 like Porcine B-cells have 
the highest Proliferative capacity in 
response to Tlr stimulation
We next investigated the proliferative response of B  cell subsets 
using multicolor flow cytometry with CellTrace Violet staining. 
The identification of P1-P4 B-cell subsets was not possible due to an 
apparent loss of CD11R1 expression in culture after 5 days (data not 
shown). We therefore gated for CD21+IgM+, CD21−/lowIgM+, and 
IgG+ cells subset (Figure  4A). A representative CellTrace Violet 
staining of the three subsets is shown in Figure 4B and a summary 
of all biological replicates in Figure 4C. Similar to the induction of 
CD25 and CCR7 expression, Pam3Cys-SK4 and resiquimod were 
found to be the most potent inducers of proliferation. Only the 
IgG+ B-cell subset was unresponsive to the CpG stimulation. When 
comparing the three gated subsets, we found the CD21−/lowIgM+ 
subset to have the strongest response to all three TLR ligands.
Considering the uncertainty with respect to the identity of 
the above B-cell subsets, we FACS-sorted the four B-cell subsets 
P1–P4 before stimulation with resiquimod and determined the 
proliferation by 3H-thymidine incorporations as in Figure  1A. 
The results demonstrated that P3 was the B-cell subset with the 
highest proliferative potential (Figure 4D).
cD21−igM+ B cell subsets are the Main 
source of igM Following Tlr stimulation
Considering that spontaneous IgM secretion has been found as a 
characteristic of murine and human B-1 cells (33, 35), we tested 
this function in sorted porcine B cell subsets P1–P4. As shown in 
FigUre 3 | Activation markers on B cell subsets after stimulation with toll-like receptor (TLR) ligands. (a) Histogram overlays of CD25 expression on the B cell 
subsets P1–P4 defined as shown in Figure 2. Peripheral blood mononuclear cells (PBMCs) were cultured and stimulated overnight and B-cell subset identified 
using multicolor flow cytometry. A representative animal out of three is shown. (B,c) Fluorescence intensity of CD25 and CCR7 after stimulation of PBMC with TLR 
ligands. PBMCs were stimulated overnight and B-cell subsets identified using multicolor flow cytometry. Triplicates cultures from three different animals, each 
depicted by a different symbol, are shown. Mean values are indicated by horizontal bars. Error bars show SDs. Statistical significance was calculated using ANOVA 
followed by Tukey’s test.
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Figure 5A, high levels of IgM were only found in the supernatants 
of TLR-stimulated P3 and P4 B-cell subsets. Even the addition of 
recombinant porcine IL-2 and BAFF, both previously shown to be 
required for in vitro activation of porcine memory B cells to differ-
entiate into antibody-producing cells (36), did not permit spontane-
ous IgM secretion by any B-cell subset. Nevertheless, in the presence 
of the cytokines the CD21+IgM+ P1 subset produced 38 ng/ml, but 
this value was still 39 and 85 times lower that the production found 
with P3 and P4, respectively. Altogether, this support that P3 and P4, 
although apparently unable to constitutively produce IgM, possess 
B1-like characteristics not found with conventional B cells.
Tlr ligands Promote Polyclonal igM  
and Memory B cell Differentiation to 
antibody-Producing cells
Next, we compared polyclonal IgM secretion and restimula-
tion of FMDV-specific memory B  cells to produce antibodies 
following TLR stimulation and found potent responses with 
Pam3Cys-SK4, resiquimod and ODN D-SL03 (Figures 5B,E). 
Considering that pDCs play an important role in human B cell 
activation in vitro (37), we tested the effect of pDC depletion on 
antibody responses. Also in absence of pDC, B cells were able 
to produce IgM and virus-specific antibodies following TLR 
stimulation. Interestingly, antibody levels were significantly 
increased following resiquimod stimulation but not with the 
other TLR ligands (Figures 5C,F). When the sorted ILR3+ frac-
tion containing the pDC was pooled with the negative fraction 
(“reconstituted”), the values obtained were again comparable 
to the PBMC controls indicating that the higher levels of IgM 
following resiquimod stimulation was not an effect of the 
sorting process (Figures  5D,G). In contrast to the promoting 
effect of pDC depletion on resiquimod stimulation, it resulted 
in reduced responses to FMDV antigen (PBMC compared to 
pDC-depleted P = 0.019 and pDC-depleted compared to recon-
stituted P = 0.01).
FigUre 4 | Proliferative responses of B cell subsets after stimulation with toll-like receptor (TLR) ligands (a) Gating strategy defining CD21+IgM+, CD21+IgM+, and 
IgG+ B cells, exemplified for unstimulated and Pam3Cys-SK4 stimulated peripheral blood mononuclear cells (PBMCs) after 5 days of culture. (B) CellTrace Violet 
staining of the three B-cell subsets defined in (a) using multicolor flow cytometry. PBMCs were cultured for 5d. A representative animal out of three is shown.  
(c) Percentage of proliferating B cell subsets, defined as shown in (a,B), after stimulation of PBMCs with the indicated TLR ligands. Triplicates cultures from three 
different animals are shown. (D) Proliferation of FACS-sorted B cell subsets after stimulation for 3 days was determined using 3H-thymidine incorporation. P1 was 
defined and sorted as CD21+IgM+ subset, P2 as IgG+ subset, P3 as CD21−IgM+CD11R1+ subset, and P4 as CD21−IgM+CD11R1− subset (for gate definition see 
Figure 2). (c,D) Mean values are indicated by horizontal bars. Error bars show SDs. Statistical significance was calculated using ANOVA followed by Tukey’s test.
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FigUre 5 | Antibody production after stimulation with toll-like receptor (TLR) ligands. (a) Spontaneous and induced IgM responses by B cell subsets. The B cell 
subsets P1–P4 defined as shown in Figure 2 were FACS-sorted, cultured at 0.5 × 106 cells/ml and stimulated with resiquimod in the absence or presence of 
interleukin-2 (IL-2) and B-cell activating factor (BAFF) for 5 days. IgM production in the supernatants was quantified by ELISA. (B) TLR-induced IgM production 
induced of full PBMCs, of plasmacytoid dendritic cell (pDC)-depleted PBMCs (c), and of PBMCs reconstituted with pDC following sorting (D). (e–g) FMDV-specific 
IgG-antibody levels detected in the same setup as in (B–D). (B–g) Cells were cultured for 7 days. Six biological replicates of two independent experiments are 
shown. Statistical significance was calculated using ANOVA followed by Tukey’s test (****P < 0.0001; ***P < 0.001; **P < 0.01; *P < 0.05).
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Tlr expression levels in Porcine B cells
To better understand B  cell response patterns to TLR ligand 
stimulation, we investigated TLR expression at the transcrip-
tional level using RT-qPCR, and compared results to other 
antigen-presenting cells. We first compared MACS-sorted CD21+ 
B  cells, CD14+ monocytes, and FACS-sorted CD172a+CD4+ 
pDCs (Figure  6A). B  cells expressed high levels of TLR7, 
intermediate levels of TLR8 and TLR9, and low but detect-
able levels of TLR2, TLR3, and TLR4. Dominant TLR genes 
on monocytes were TLR4 and TLR8 (although statistically not 
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significant different from other TLRs) and on pDC TLR3, TLR7, 
and TLR9.
Considering the strong responses of B cells to TLR2 ligands, 
we tested if TLR2 was upregulated following stimulation, as has 
been reported for human B cells. PBMCs were stimulated with 
Pam3Cys-SK4 and surface expression of TLR2 on CD21+ cells 
was analyzed by flow cytometry. After 24 h, a potent upregulation 
of TLR2 was detected (Figure 6B).
We next analyzed TLR expression by RT-qPCR on sorted 
B-cell subsets as defined in Figure  2. Only the expression of 
TLR3 on the P4 subset was found to be significantly higher when 
compared to P1 and P2. Nevertheless, TLR3 transcripts were 
also found in P3 but were absent in P1 and P2. This contrasted 
with the TLR4 expression, which was undetectable in the B-1 
like subsets but present in P1 and P2, although at low levels 
(Figure 6C).
activation Marker response of Dc 
subsets and Monocytes
In the perspective of vaccine development, and to compare 
B cell TLR responsiveness to other antigen-presenting cells, we 
decided to investigate activation markers of blood dendritic 
cell subsets and monocytes after stimulation with the TLR 
ligands used for the B  cell stimulations. The subsets defini-
tions are shown in Figure 7A and are based on previous work 
(26, 29). After 5 h of stimulation with all ligands tested, CD40 
expression was increased on cDC1 cells and monocytes. cDC2 
cells responded to all ligands, with the exception of CpG ODN 
D-SL03. CD40 was also upregulated on pDCs in response 
to most ligands, with the exception of MPLA. The highest 
responses were seen with resiquimod (Figure  7B). CCR7 
was not induced in cDC1 cells by MPLA and ODN D-SL03. 
Also, in cDC2 and pDC, MPLA was unable to induce CCR7 
(Figure 7C). Interestingly, high induction of CCR7 occurred 
in pDCs, particularly after stimulation with gardiquimod and 
resiquimod.
DiscUssiOn
It is well established in mouse models that TLR stimulation 
of B  cells provides important signals for the differentiation of 
naïve B cells into antibody-producing cells in response to both 
T-dependent and -independent antigens. In this process, TLR 
signals promote germinal center formation, affinity maturation, 
and isotype switching (13, 38–42). Targeting these pathways is 
relevant to improving vaccines, understanding humoral responses 
to microbes, treating autoimmunity, and even understanding 
B cell malignancy development.
We have shown that porcine B  cells respond to triggering 
by several TLR ligands, the strongest being TLR2/X, TLR7/8, 
and TLR9. These findings are comparable with those for human 
B  cells, although some differences were observed. In human 
B  cells, proliferation induced by TLR7/8 ligands was pDC-
dependent (37). With porcine cells, gardiquimod, described as 
pure TLR7 ligand, also lost its activity when pure B cells were 
compared with PBMCs, indicating a possible role for pDCs. 
Resiquimod, described as TLR7/TLR8 ligand, also induced 
high responses in purified porcine B cells. Pure porcine B cells 
responded to CpG similarly to their human counterparts. 
Human B  cells are also stimulated via TLR3 (14), which did 
not or very weakly occur in the porcine model. Some studies 
described B cell activation following stimulation with TLR2/X 
ligands (14, 43), but our work found that proliferation of porcine 
cells is higher. Murine B cells responses have been reported to be 
much stronger following TLR4 as compared to TLR2/X, TLR7, 
and TLR9 stimulation (12, 44), in contrast with porcine and 
human B cells. These differences need to be considered when 
selecting TLR ligands as potential vaccine adjuvants targeting 
B cells.
It is interesting to note that in all three species, TLR7 and TLR9 
expression dominates in B cells, indicating an important role in 
sensing viral infections. This possibility is supported by in vivo 
studies in mice (20, 22–24).
Compared to whole PBMCs, purified B  cells responded 
in a more homogenous manner. Again, stimulation through 
TLR2/6, TLR7/8, and TLR9 induced high levels of prolifera-
tion, confirming a direct triggering of their receptors on B cells. 
Of course, this fact does not exclude the possibility that other 
signals such as IFN-α or IFN-λ derived from pDCs may fur-
ther enhance B cell responses to such ligands, as described in 
humans (45).
Looking closer into porcine peripheral B  cells, we identi-
fied subsets based on expression of IgG and IgM, CD21, and 
CD11R1. These included a major CD21+IgM+ subset termed 
P1, probably representing mostly naïve B cells. Nevertheless, as 
there is no marker for memory B cells available in the pig, we 
cannot exclude the presence of some IgM expressing memory 
B  cells. The second subset expressed surface IgG (subset P2) 
and must therefore have undergone isotype switching indicat-
ing memory status. Finally, we identified two novel putative 
B1-like subsets, both being larger in size, expressing high levels 
of IgM, CD80/86, and having a higher level of spontaneous 
PLC-γ2 phosphorylation, characteristics also found with B-1 
cells in other species (32–34, 46). Within these B-1 like cells, 
we found two clearly distinct subsets, a major population 
of B  cells expressing CD11R1 (probably representing the 
porcine homolog of CD11b) and CD14, reminiscent of a B-1 
cell subset  also described in human blood (32). Interestingly, 
the majority of both B-1 like subsets expressed high levels of 
CD11c, a molecule typically expressed on monocytic cells and 
DC in the pig (26, 47). However, the P3 and P4 subsets can be 
classified as B cells based on their expression of IgM and CD79b 
(data not shown) but lack of CD115 and CD172a. It should be 
noted that CD5 has been ruled out as a marker for porcine 
B-1 cells (48), and was therefore not included in our analyses. 
Clearly, future studies are required to identify their relationship 
to murine and human B-1 cells, their tissue distribution, B-cell 
receptor rearrangement, and function.
The data in the present manuscript demonstrated that all 
porcine B-cell subsets are activated by TLR2 and TLR7 ligands, 
although some differences were found. Our data indicate that in 
the pig naïve and memory conventional B cells respond similar to 
TLR ligand stimulation in terms of CD25, CCR7 upregulation and 
FigUre 6 | Toll-like receptor (TLR) mRNA expression in B cells, monocytes, and plasmacytoid dendritic cells (pDCs). (a) CD21+ B cells and CD14+ monocytes were 
sorted by magnetic cells sorting (purity > 98%); CD172a+CD4high pDCs were purified by fluorescence activated cell sorting (FACS) (purity > 99%). RNA was isolated 
for RTqPCR analysis of TLR expression. Data are from three biological replicates generated using cells from three different pigs. In B cells, TLR7 expression was 
significantly higher than all other TLR (***P < 0.0001). In pDC, TLR3, TLR7, and TLR9 were found to be significantly higher when compared to the other TLRs 
(**P < 0.001). (B) Expression of TLR2 on CD21+ cells after stimulation of peripheral blood mononuclear cells with Pam3Cys-SK4 for 24 h. A representative 
experiment from three independent experiments is shown. (c) TLR mRNA expression of B cell subsets P1–P4 sorted by FACS according to the gates defined in 
Figure 2. Mean values calculated from three different animals with standard deviations are shown. P4 was statistically significant from P1 and P2 for TLR3 
expression (*P < 0.05).
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proliferation. The CD11R1+ B1-like subset was the most potent in 
terms of proliferative responses, relating to its known prolifera-
tive capacity (49, 50). This contrasted with the CD11R1− B1-like 
subset, which was generally the least TLR-responsive subset.
Analysis of sorted B-cell subset surprisingly demonstrated 
that only the porcine B-1 like subsets P3 and P4, but not the 
major CD21+IgM+ P1 subset, were able to secrete IgM following 
TLR stimulation. This contrasted with data comparing in  vitro 
secretion of Ig by murine B cell subsets. While these studies gen-
erally showed a higher IgM secretion by B-1 and marginal zone 
(MZ) B cells, also follicular B cells readily produce all Ig isotypes 
including IgM following TLR stimulation (12, 50). Nevertheless, 
comparing B cell subset from different anatomical sources should 
be interpreted with caution. Also contrasting to human B-1 cells 
isolated from the peripheral blood (33), we found that neither 
of the porcine B-1 like subsets constitutively secreted IgM. 
Nevertheless, the levels of spontaneous IgM secretion were also 
very low in murine B1 cells (50).
We also analyzed a possible differential expression of TLR 
transcripts on porcine B cells and found possible differences in 
FigUre 7 | Activation marker response of DC subsets after stimulation with toll-like receptor (TLR) ligands. Peripheral blood mononuclear cells were cultured with 
TLR ligands for 5 h, and activation marker expression on mononuclear subsets was determined using five-color flow cytometry. (a) Gating strategy for identifying 
conventional DC1 (cDC1), cDC2, and plasmacytoid dendritic cell (pDC) subsets. After doublet exclusion and forward/side scatter gating on large cells, monocytes 
were identified as CD14+ cells, cDC1 as CD14−CD172alowCADM1+, cDC2 as CD14−CD172ahighCADM+, and pDC as CD14−CD172+CD4+. (B) CD40 levels.  
(c) CCR7 levels on mononuclear cell subsets. The figure shows biological replicates of three independent experiments. Statistical significance was calculated using 
ANOVA followed by Tukey’s test (****P < 0.0001; ***P < 0.001; **P < 0.01; *P < 0.05).
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the expression of TLR3 and TLR4. While TLR3 transcripts were 
only found on the B-1 like subsets P3 and P4, TLR4 appeared 
to be restricted to conventional B cells. The functional conse-
quence of this requires follow-up studies but these data further 
support the identification of distinct B cell subsets. In murine 
B  cell, TLR expression on different B  cell subsets was overall 
similar with a dominating expression of TLR7 and TLR9 in all 
subsets (12, 50). Only in MZ, B cells elevated TLR3 transcripts 
were found (50).
The interpretation of our data on B-1 like cells in the pig 
requires future studies defining their identity and functional 
role. It is obvious that species-specific differences in the biology 
of innate like B cells exist, even when comparing laboratory mice 
with wild living mice species (51).
As in human B cells, we found that in porcine cells, resiqui-
mod and CpG induced polyclonal and antigen-specific antibody 
responses in the absence of antigen, demonstrating TLR-driven 
differentiation of memory B cells into antibody-producing cells. 
CpG was particularly efficient in this process. Contrary to in vitro 
findings using human B cells (37), depletion of pDCs from the 
cultures did not abrogate secretion of IgM or FMDV-specific 
IgG antibodies. On the contrary, we even detected enhanced 
responses to resiquimod suggesting that pDC produce inhibitory 
factors. It is unlikely that IFN type I represents such an inhibi-
tory factor as CpG stimulation is by far the most potent IFN-α 
inducer for porcine pDC (25, 26, 52), and pDC depletion had 
no influence on CpG-induced antibody responses. On the other 
hand, the observations that purified B cells poorly responded to 
TLR stimulation in terms of antibody production indicates that 
other co-stimulatory factors are important. For restimulation of 
FMDV-specific memory B  cells, we have previously identified 
T-cell-derived IL-2 and monocyte-derived BAFF to be essential 
(36). It is possible that such factors are also important for TLR-
driven antibody responses.
In the light of previous findings showing the importance of 
innate activation for potent B cell response, we also evaluated 
ligands targeting B  cells for their ability to activate dendritic 
cells. We found high responsiveness of cDC1, cDC2, and pDCs 
in terms of CD40 induction, with the same ligands found to be 
potent B cell activators. Of particular interest are gardiquimod 
and resiquimod, as they strongly induced CCR7 expression in 
pDCs. This would promote their ability to migrate to lymphoid 
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tissue, where IFN-α secreting pDCs could impact B  cell 
differentiation.
We conclude that combinations of such ligands are promising 
as vaccine adjuvants are able to promote T and B cell responses. 
While such approaches may be rewarding for pig vaccines, the 
greater similarity of some aspects of the porcine and human 
immune systems compared to mice (29, 53–56) is an argument 
for pigs as an additional animal model for human vaccines or 
immunotherapeutics.
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